NexHealth
NexHealth develops a platform for healthcare providers, using its Synchronizer API to automate scheduling, payments, and patient data integration.
Secondary Market Price
How NexHealth Measures Up
To help you manage your NexHealth equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series C
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of NexHealth's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future NexHealth Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for NexHealth's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
NexHealth is a technology company that provides a patient experience platform for healthcare providers and software developers. The company's services focus on connecting aspects of the patient journey, such as scheduling and payments, directly with health record systems to streamline practice operations. A core component of its offering is the Synchronizer API, which facilitates real-time data synchronization between a practice's management system and other healthcare software. Founded in 2017 by Alamin Uddin and Waleed Asi, the San Francisco-based company has raised a total of $48.7 million.
The company's future plans center on the continued development of its Synchronizer platform with the stated goal of achieving full data interoperability in healthcare. NexHealth has announced a live stream to present its product roadmap through 2026. Recent company activities include the publication of case studies to demonstrate the platform's use, such as one with Operation Dental, which reported a 25% increase in new patients after implementation. The company also launched a "Synchronizer Wins" series to highlight customer stories and has publicly commented on federal enforcement against data blocking, aligning with its mission for open data access.
- Buckley Ventures
- Point Nine Capital
- Rubicon Venture Capital
- iSeed Ventures
- Lachy Groom
- Jack Altman
- Scott Belsky
- Shreyas Doshi
- Eric Glyman
- Shahed Khan
- Packy McCormick
- Rahul Vohra
- Josh Buckley
- Naval Ravikant
- Josh Hannah
- Co-Founder, Alamin Uddin
- Co-Founder, Waleed Asif
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is NexHealth worth joining?
Deciding whether to join any startup, including NexHealth, depends on your personal career goals and how you view the potential risks and rewards. Platforms like Prospect can help you make an informed choice by providing data-driven projections of a company's equity value.
What should I do with my NexHealth stock?
Managing private company stock like NexHealth's involves making strategic decisions about when to exercise options, plan for taxes, and potentially sell your shares. To navigate these complexities, you can use a service like Prospect, which builds customized, multi-year strategies for your equity.
Can you sell NexHealth stock?
Selling stock in a private company like NexHealth is typically possible during specific liquidity events, such as a tender offer or a secondary sale. Tools from Prospect can help you determine the optimal shares to sell for tax purposes and decide how much to sell during these opportunities.
How can I find the value of my NexHealth stock?
Valuing stock in a private company is challenging because it isn't traded on a public exchange and its financial information is not widely available. You can use platforms like Prospect, which use machine learning models and proprietary data to project the value of your private equity.
What is NexHealth's equity worth?
The precise worth of NexHealth's equity is not public information and depends on factors like its latest valuation, performance, and market conditions. To get a clearer picture, services like Prospect analyze various data points to forecast a likely range of outcomes for a startup's equity.
What is NexHealth's stock ticker symbol?
As a private company, NexHealth does not have a stock ticker symbol because its shares are not traded on a public stock exchange. A ticker symbol is only assigned when a company completes an initial public offering (IPO) and lists on an exchange like the NYSE or NASDAQ.
Can I buy or sell NexHealth stock?
You can typically "buy" stock by exercising your vested options, and you can sell it during company-approved liquidity events like tender offers. Platforms like Prospect provide analysis and strategies to help you optimize both the timing of exercising options and selling shares.
What is the criteria to buy or invest in NexHealth stock?
Investing in a private company like NexHealth is generally restricted to employees receiving equity compensation or accredited investors participating in funding rounds or secondary markets. The criteria are set by the company and securities regulations, and it is not typically open to the general public for direct investment.
